Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Herbal mixture used for prostate cancer found to have potent estrogenic effects

Oct. 15, 1998

Siga will collaborate with Ludwig Institute to develop cancer vaccines

Oct. 15, 1998

CEA-Cide receives orphan drug designation

Oct. 14, 1998

Demegen receives patent protection for Peptidyl MIMs in cancer indications

Oct. 14, 1998

U.S. patent covers protegrins and synthetic analogues such as IntraBiotics' IB-367

Oct. 14, 1998

Bicyclic inhibitors of protein farnesyltransferase for cancer, restenosis, etc.

Oct. 14, 1998

Novel series of inhibitors of protein farnesyltransferase developed at RPR

Oct. 14, 1998

Introgen acquires option to license Bak gene from LXR

Oct. 14, 1998

Hybridon advances antisense drug to phase II

Oct. 14, 1998

Aphton initiates phase I/II trial of Gonadimmune in prostate cancer patients

Oct. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...